Blood Market by Product [Whole Blood Collection: Global Opportunity Analysis and Industry Forecast, 2017-2023

  • ID: 4333223
  • Report
  • Region: Global
  • 63 pages
  • Allied Analytics LLP
1 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • Baxter International Inc.
  • Becton, Dickinson & Co.
  • Csl Behring
  • Grifols International Sa
  • Immucor
  • MORE
Blood is a major necessity for patients suffering from injuries and viral infections, which require blood transfusion. The patients are either given whole blood or blood components for quick recovery and healing, resulting into increased demand for blood banks.

The global blood market was valued at $33,500 million in 2016, and is estimated to reach $45,982 million by 2023, registering a CAGR of 4.6% from 2017 to 2023. The major factors that enhance the market growth are increase in geriatric population, rise in trauma cases, technological advancement in medical technology for donor screening, and advancement in blood transfusion instruments. However, rise in minimal invasive technology, which no longer requires blood transfusion restrains the market growth.

The global blood market is segmented by product, end user, and geography. Based on product, it is divided into whole blood collection, source plasma collection, blood therapeutics, blood typing products, blood screening, and blood processing equipment & associated products. Blood therapeutics segment contributed the highest share in 2016, owing to the increase in the demand for various plasma proteins for the recovery of patients. Based on whole blood collection, the market is bifurcated into system and reagents. On the basis of source plasma collection, it is divided into system and reagents. Blood therapeutics are categorized into intravenous immunoglobulin (IVIG), factor IX, factor VIII, hyperimmune, and albumins. Blood typing products are classified into system and reagents. Blood screening is further divided into systems and reagents. Blood processing equipment & associated products are categorized into systems and reagents.

Geographically, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. The North America market accounted for significant share in the global market in 2016, owing to a well-developed healthcare industry and rise in number of patient population requiring blood & blood components.

KEY BENEFITS

The study provides an in-depth analysis of the global blood market, with the current trends and future estimations to elucidate the imminent investment pockets.
The report provides quantitative analysis of the industry from 2016 to 2023 to enable stakeholders to capitalize on the prevailing opportunities.
Extensive analysis of the market based on the product and end user elucidates the prevailing opportunities in these segments.
Comprehensive analysis of geographical regions is provided to determine the latent regional opportunities.

Key players operating in the market and their strategies are profiled to determine the competitive outlook of the market.

KEY MARKET SEGMENTS

BY PRODUCT

Whole Blood Collection
Whole Blood Collection Systems
Whole Blood Collection Reagents
Source Plasma Collections
Source Plasma Collection Systems
Source Plasma Collection Reagents
Blood Therapeutics
IVIG (Intravenous Immunoglobulin)
Factor IX
Factor VIII
Hyperimmune
Albumins
Blood Typing Products
Blood Typing Systems
Blood Typing Reagents
Blood Screening
Blood Screening Systems
Blood Screening Reagents
Blood Processing Equipment & Associated Products
Blood Processing Equipment Systems
Blood Processing Equipment Reagents

BY END USER

Blood & Blood Component Bank
Diagnostic Laboratories
Ambulatory Surgical Centers
Hospitals
Others (Academic Institutes & Research Laboratories)

BY GEOGRAPHY

North America
U.S.
Canada
Mexico
Europe
UK
France
Germany
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Rest of Asia-Pacific
LAMEA
Latin America
Middle East
Africa
LIST OF KEY PLAYERS PROFILED IN THE REPORT

Abbott Laboratories
Becton, Dickinson & Co.
Baxter International Inc.
CSL Behring
Grifols International SA
Immucor
Novartis
Novo Nordisk
Ortho Clinical Diagnostics
Roche Diagnostics
LIST OF OTHER PLAYERS IN THE VALUE CHAIN

(These players are not profiled in the report, but can be included on request)

Medimmune (AstraZeneca)
Fresenius Kabi
Macopharma
Nipro Medical Corporation
Sarstedt AG & Co.
Thermo Fisher Scientific, Inc.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • Baxter International Inc.
  • Becton, Dickinson & Co.
  • Csl Behring
  • Grifols International Sa
  • Immucor
  • MORE
CHAPTER 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top winning strategies
3.2.2. Top investment pockets

3.3. MARKET SHARE ANALYSIS,2016
3.4. PORTERS FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS

3.5.1. Drivers

3.5.1.1. Increase in geriatric population
3.5.1.2. Technological advancement in medical technology for donor screening
3.5.1.3. Advancement in blood transfusion instruments

3.5.2. Restraints

3.5.2.1. Advancement in minimal invasive technology

3.5.3. Opportunities

3.5.3.1. Improvement in the healthcare facilities in Asia-Pacific

CHAPTER 4 BLOOD MARKET, BY PRODUCT

4.1. OVERVIEW
4.2. WHOLE BLOOD COLLECTION

4.2.1. Key market trends
4.2.2. Key growth factors and opportunities
4.2.3. Market size and forecast
4.2.4. Market by whole blood collection type

4.2.4.1. Whole Blood Collection Systems

4.2.4.1.1. Market size and forecast

4.2.4.2. Whole Blood Collection Reagents

4.2.4.2.1. Market size and forecast

4.3. SOURCE PLASMA COLLECTION

4.3.1. Key market trends
4.3.2. Key growth factors and opportunities
4.3.3. Market size and forecast
4.3.4. Source Plasma Collection Systems

4.3.4.1. Market size and forecast

4.3.5. Source Plasma Collection Reagents

4.3.5.1. Market size and forecast

4.4. BLOOD THERAPEUTICS

4.4.1. Key market trends
4.4.2. Key growth factors and opportunities
4.4.3. Market size and forecast
4.4.4. IVIG (Intravenous Immunoglobulin)

4.4.4.1. Market size and forecast

4.4.5. Factor IX

4.4.5.1. Market size and forecast

4.4.6. Factor VIII

4.4.6.1. Market size and forecast

4.4.7. Factor IX

4.4.7.1. Market size and forecast

4.4.8. Hyperimmune

4.4.8.1. Market size and forecast

4.4.9. Albumins

4.4.9.1. Market size and forecast

4.4.10. Others

4.4.10.1. Market size and forecast

4.5. BLOOD TYPING PRODUCTS

4.5.1. Key market trends
4.5.2. Key growth factors and opportunities
4.5.3. Market size and forecast
4.5.4. Blood Typing Systems

4.5.4.1. Market size and forecast

4.5.5. Blood Typing Reagents

4.5.5.1. Market size and forecast

4.6. BLOOD SCREENING

4.6.1. Key market trends
4.6.2. Key growth factors and opportunities
4.6.3. Market size and forecast
4.6.4. Blood Screening Systems

4.6.4.1. Market size and forecast

4.6.5. Blood Screening Reagents

4.6.5.1. Market size and forecast

4.7. BLOOD PROCESSING EQUIPMENT AND ASSOCIATED PRODUCTS

4.7.1. Key market trends
4.7.2. Key growth factors and opportunities
4.7.3. Market size and forecast
4.7.4. Blood Processing Equipment Systems

4.7.4.1. Market size and forecast

4.7.5. Blood Processing Equipment Reagents

4.7.5.1. Market size and forecast

CHAPTER 5 BLOOD MARKET, BY END USER

5.1. OVERVIEW
5.2. BLOOD & BLOOD COMPONENT BANK

5.2.1. Market size and forecast

5.3. DIAGNOSTIC LABORATORIES

5.3.1. Market size and forecast

5.4. AMBULATORY SURGICAL CENTERS

5.4.1. Market size and forecast

5.5. HOSPITALS

5.5.1. Market size and forecast

CHAPTER 6 BLOOD MARKET, BY GEOGRAPHY

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. NORTH AMERICA

6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. Market size and forecast
6.2.4. U.S.: market size and forecast
6.2.5. Canada: market size and forecast
6.2.6. Mexico: market size and forecast

6.3. EUROPE

6.3.1. Key market trends
6.3.2. Key growth factors and opportunities
6.3.3. Market size and forecast
6.3.4. Germany: market size and forecast
6.3.5. France market size and forecast
6.3.6. UK: market size and forecast
6.3.7. Italy: market size and forecast
6.3.8. Spain: market size and forecast
6.3.9. Rest of Europe: market size and forecast

6.4. ASIA-PACIFIC

6.4.1. Key market trends
6.4.2. Key growth factors and opportunities
6.4.3. Market size and forecast
6.4.4. Japan: market size and forecast
6.4.5. China market size and forecast
6.4.6. India: market size and forecast
6.4.7. Rest of Asia-Pacific market size and forecast

6.5. LAMEA

6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. Market size and forecast
6.5.4. Latin America: market size and forecast
6.5.5. Middle East market size and forecast
6.5.6. Africa: market size and forecast

CHAPTER 7 COMPANY PROFILES

7.1. ABBOTT LABORATORIES

7.1.1. Overview
7.1.1. Operating business segments
7.1.1. Business performance
7.1.2. Key strategic moves & developments

7.2. BAXTER INTERNATIONAL INC.

7.2.1. Overview
7.2.2. Operating business segments
7.2.3. Business performance
7.2.4. Key strategic moves & developments

7.3. BECTON, DICKINSON & CO.

7.3.1. Overview
7.3.2. Operating business segments
7.3.3. Business performance
7.3.4. Key strategic moves & developments

7.4. CSL BEHRING

7.4.1. Overview
7.4.2. Operating business segments
7.4.3. Business performance
7.4.4. Key strategic moves & developments

7.5. IMMUCOR

7.5.1. Overview
7.5.2. Operating business segments
7.5.3. Business performance
7.5.4. Key strategic moves & developments

7.6. NOVARTIS

7.6.1. Overview
7.6.2. Operating business segments
7.6.3. Business performance
7.6.4. Key strategic moves & developments

7.7. NOVO NORDISK

7.7.1. Overview
7.7.2. Operating business segments
7.7.3. Business performance
7.7.4. Key strategic moves & developments

7.8. ORTHO CLINICAL DIAGNOSTICS

7.8.1. Overview
7.8.2. Operating business segments
7.8.3. Business performance
7.8.4. Key strategic moves & developments

7.9. ROCHE DIAGNOSTICS

7.9.1. Overview
7.9.2. Operating business segments
7.9.3. Business performance
7.9.4. Key strategic moves & developments

7.10. GRIFOLS INTERNATIONAL SA

7.10.1. Overview
7.10.2. Operating business segments
7.10.3. Business performance
7.10.4. Key strategic moves & developments
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • Baxter International Inc.
  • Becton, Dickinson & Co.
  • Csl Behring
  • Grifols International Sa
  • Immucor
  • MORE
According to a new report titled, "Blood Market by Product and End User: Global Opportunity Analysis and Industry Forecast, 2017-2023," the global blood market was valued at $33,500 million in 2016, and is projected to reach $45,982 million by 2023, registering a CAGR of 4.6% from 2017 to 2023. The blood therapeutics segment contributed the highest share in 2016, owing to the increase in the demand for various plasma proteins for the recovery of patients.

The blood market products include whole blood collection, source plasma collection, blood therapeutics, blood typing products, blood screening, and blood processing equipment & associated products. Increase in geriatric population, rise in trauma cases, technological advancement in medical technology for donor screening, and advancement in blood transfusion instruments drive the market growth. However, rise in minimal invasive technology, which no longer require the blood transfusion hamper the market growth. Increase in peripheral nerve injuries and improvement in the healthcare facilities in Asia-Pacific provide growth opportunities for the market.

Blood & blood component banks contributed the highest share in 2016, owing to the increase in the demand for using equipment for the blood processing and for segregation of the blood components. North America accounted for significant share in the global market in 2016, owing to an established healthcare industry and rise in number of patient population requiring blood & blood components.

Key Findings of the Blood Market:

In 2016, the blood therapeutics segment accounted for the highest share of the global blood industry market.
The intravenous immunoglobulin segment contributed the highest revenue to the global market in 2016.
The blood & blood component banks segment is projected to grow at the highest CAGR of 4.9% during the forecast period.
North America is projected to grow at a CAGR of 4.4%.
The major companies profiled in the report include Abbott Laboratories, Baxter International Inc., Becton, Dickinson & Co., CSL Behring, Immucor, Novartis, Novo Nordisk, Ortho Clinical Diagnostics, Roche Diagnostics, and Grifols International SA.
Note: Product cover images may vary from those shown
5 of 5
  • Abbott Laboratories
  • Becton, Dickinson & Co.
  • Baxter International Inc.
  • Csl Behring
  • Grifols International Sa
  • Immucor
  • Novartis
  • Novo Nordisk
  • Ortho Clinical Diagnostics
  • Roche Diagnostics
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll